Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia (Q35813037)
Jump to navigation
Jump to search
scientific article published on 19 October 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia |
scientific article published on 19 October 2015 |
Statements
1 reference
Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia (English)
1 reference
Jia Luo
1 reference
Lawren VandeVrede
1 reference
Zhihui Qin
1 reference
Sujeewa Piyankarage
1 reference
Ehsan Tavassoli
1 reference
Rezene T Asghodom
1 reference
Manel Ben Aissa
1 reference
Mauro Fà
1 reference
Lan Yue
1 reference
David R Pepperberg
1 reference
Gregory R J Thatcher
1 reference
19 October 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference